In the news
05.02.2026
44,6 Millionen Euro für ein KI-Start-up, das klinische...
Handelsblatt news article about Biorce.
About Biorce
Biorce is an AI healthtech startup, building defensible AI solutions for clinical trial development. Its platform, Aika, is a continuous intelligent layer, from protocol decision to regulatory submission, enabling fewer amendments and a dramatic reduction of cost and time.
Media contact
Lynn Caroline Broeker
PR & Media collaborations
lynn.broeker@biorce.com
AI-accelerated protocol creation, feasibility, and alignment.
for journalists, bloggers or
multipliers
Get in touch
AI-accelerated protocol creation, feasibility, and alignment.
for journalists, bloggers or
multipliers
Get in touch
AI-accelerated protocol creation, feasibility, and alignment.
for journalists, bloggers or
multipliers
Get in touch
AI-accelerated protocol creation, feasibility, and alignment.
browse and download high quality images and video footage
Access gallery
browse and download high quality images and video footage
Access gallery
AI-accelerated protocol creation, feasibility, and alignment.
browse and download high quality images and video footage
Access gallery
AI-accelerated protocol creation, feasibility, and alignment.
Essential facts and background on key topics.
Collected topics
AI-accelerated protocol creation, feasibility, and alignment.
Essential facts and background on key topics.
Collected topics
AI-accelerated protocol creation, feasibility, and alignment.
Essential facts and background on key topics.
Collected topics
Get the inside track on clinical trial innovation Insights that pharma leaders actually read. No fluff.
@2026 Biorce | All Rights Reserved
Partners with
Get the inside track on clinical trial innovation Insights that pharma leaders actually read. No fluff.
Partners with
@2026 Biorce | All Rights Reserved
Get the inside track on clinical trial innovation Insights that pharma leaders actually read. No fluff.
@2026 Biorce | All Rights Reserved
Partners with